Studies have shown that active fund managers routinely underperform the S&P500 index*​

Home

Articles

WALL STREET X

Forecasts

Portfolios

Editas Medicine, Inc. (NASDAQ: EDIT)

EDIT Stock Predictions and Ratings

WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-44.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
87.10%

EDIT Stock Analysis

EDIT PE Ratio:

EDIT PEG Ratio: Not Available

EDIT Forward EPS Growth (12 month): 0.00%

EDIT PS Ratio: 7

EDIT PSG Ratio: -0.2

EDIT Forward Revenue Growth (12 month): -40.30%

EDIT Articles

No data was found